3-메칠-(O-치환된 옥시이미노)-피라졸린-5-온 유도체를함유하는 항암제
    5.
    发明公开
    3-메칠-(O-치환된 옥시이미노)-피라졸린-5-온 유도체를함유하는 항암제 失效
    3-甲基 - (O-取代的氧代) - 吡唑啉-5-酮衍生物作为抗肿瘤剂

    公开(公告)号:KR1020050031716A

    公开(公告)日:2005-04-06

    申请号:KR1020030067964

    申请日:2003-09-30

    CPC classification number: A61K31/4152 A61K9/0053

    Abstract: An anticancer composition comprising 3-methyl-(O-substituted oximino)-pyrazolin-5-one derivatives is provided, which derivatives inhibit activity of CDC25B enzyme which participates in cell differentiation and is overexpressed in cancer cells. The anticancer composition comprises 3-methyl-(O-substituted oximino)-pyrazolin-5-one derivatives represented by formula (1), and pharmaceutically acceptable salts thereof, wherein R1 is C1-C4 alkyl or substituted phenyl with a substituent that is one or more selected from hydrogen, halogen atom, C1-C4 alkyl, C1-C4 alkoxy, C2-C4 acyl and nitro; and R2 is C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C2-C4 acyl, methanesulfonyl, toluenesulfonyl, C1-C4 alkoxycarbonylmethyl, carboxymethyl or inorganic metal or organic amine salts of carboxymethyl.

    Abstract translation: 提供包含3-甲基 - (O-取代的肟基) - 吡唑啉-5-酮衍生物的抗癌组合物,该衍生物抑制参与细胞分化且在癌细胞中过表达的CDC25B酶的活性。 抗癌组合物包含由式(1)表示的3-甲基 - (O-取代的肟基) - 吡唑啉-5-酮衍生物及其药学上可接受的盐,其中R1是C1-C4烷基或具有取代基的取代苯基 或更多选自氢,卤素原子,C 1 -C 4烷基,C 1 -C 4烷氧基,C 2 -C 4酰基和硝基; R2为C1-C4烷基,C2-C4烯基,C2-C4炔基,C2-C4酰基,甲磺酰基,甲苯磺酰基,C1-C4烷氧基羰基甲基,羧甲基或羧甲基的无机金属或有机胺盐。

Patent Agency Ranking